Profile

MD, Yale University





SPRINT Senior Main
09/24/2010 - 12/31/2016 (PI)
Univ of Utah NIH-NHLBI

SPRINT: Mind Sub-Study
09/14/2009 - 12/31/2016 (PI)
Univ of Utah NIH-NHLBI

SPRINT: Mind Sub-Study - Obj 2
09/14/2009 - 12/31/2016 (PI)
Univ of Utah NIH-NHLBI

SPRINT: Systolic blood pressure intervention trial
09/14/2009 - 12/31/2016 (PI)
Univ of Utah NIH-NHLBI

Determinants of Hemodialysis AV Fistula Maturation
09/10/2008 - 05/31/2013 (PI)
NIH-NIDDK
5U01 DK082232-04

Determinants of Hemodialysis AV Fistula Maturation
09/30/2009 - 12/31/2011 (PI)
NIH-NIDDK
3U01 DK082232-02S1

A Novel Dialysis Needle with Guiding Technology
09/01/2010 - 08/31/2011 (PI)
Brigham & Women's Wallace H. Coulter F

Dialysis Access Consortium Clinical Trials
06/01/2006 - 02/28/2009 (PI)
NIH-NIDDK
5U01 DK058986-07(B)

Effect Of Clopidogrel On Early
09/30/2000 - 02/28/2006 (PI)
NIH-NIDDK
3 U01 DK58986-05 S2


Title


Yr Title Project-Sub Proj Pubs
2024 A Hybrid Type 1 Effectiveness-Implementation Study of Education Strategies for Vascular Access Creation in Advanced Kidney Disease 5R01DK132367-02
2024 UPENN Scientific and Data Research Center for the HOPE Consortium to Reduce Pain and Opioid Use in Hemodialysis 4U01DK123813-02
2024 Continuation of the Chronic Renal Insufficiency Cohort (CRIC) 5U24DK060990-24
2023 A Hybrid Type 1 Effectiveness-Implementation Study of Education Strategies for Vascular Access Creation in Advanced Kidney Disease 1R01DK132367-01A1
2023 Continuation of the Chronic Renal Insufficiency Cohort (CRIC) 2U24DK060990-23
2022 Continuation of the Coordinating Center for the Chronic Renal Insufficiency Cohort (CRIC) Study 5U24DK060990-22
2021 UPENN Scientific and Data Research Center for the HOPE Consortium to Reduce Pain and Opioid Use in Hemodialysis  3U01DK123813-01S2
2020 UPENN Scientific and Data Research Center for the HOPE Consortium to Reduce Pain and Opioid Use in Hemodialysis  3U01DK123813-01S1
2019 UPENN Scientific and Data Research Center for the HOPE Consortium to Reduce Pain and Opioid Use in Hemodialysis 1U01DK123813-01
2018 Data Coordinating Center for Hemodialysis Pilot Studies Consortium 3U01DK099919-05S2 2
Showing 10 of 44 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Terry CM, Dember LM. Novel therapies for hemodialysis vascular access dysfunction: myth or reality? Clin J Am Soc Nephrol. 2013 Dec; 8(12):2202-12. PMID: 24235283; PMCID: PMC3848408; DOI: 10.2215/CJN.07360713;
     
  2. Dember LM, Imrey PB, Beck GJ, Cheung AK, Himmelfarb J, Huber TS, Kusek JW, Roy-Chaudhury P, Vazquez MA, Alpers CE, Robbin ML, Vita JA, Greene T, Gassman JJ, Feldman HI. Objectives and design of the hemodialysis fistula maturation study. Am J Kidney Dis. 2014 Jan; 63(1):104-12.View Related Profiles. PMID: 23992885; PMCID: PMC4134933; DOI: 10.1053/j.ajkd.2013.06.024;
     
  3. Berns JS, Dember LM. Can frequent hemodialysis be too frequent? J Am Soc Nephrol. 2013 Feb; 24(3):334-6. PMID: 23411783; DOI: 10.1681/ASN.2013010007;
     
  4. Peden EK, Leeser DB, Dixon BS, El-Khatib MT, Roy-Chaudhury P, Lawson JH, Menard MT, Dember LM, Glickman MH, Gustafson PN, Blair AT, Magill M, Franano FN, Burke SK. A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation. J Vasc Access. 2013 Apr-Jun; 14(2):143-51. PMID: 23172172; DOI: 10.5301/jva.5000125;
     
  5. Gopal DM, Kommineni M, Ayalon N, Koelbl C, Ayalon R, Biolo A, Dember LM, Downing J, Siwik DA, Liang CS, Colucci WS. Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure. J Am Heart Assoc. 2012 Oct; 1(5):e000760.View Related Profiles. PMID: 23316284; PMCID: PMC3541630; DOI: 10.1161/JAHA.112.000760;
     
  6. Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, Segal A, Ruberg F, Meier-Ewert H, Andrea NT, Sloan JM, Finn KT, Doros G, Blade J, Skinner M. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 2011 Oct 20; 118(16):4346-52.View Related Profiles. PMID: 21828140; PMCID: PMC3204906; DOI: 10.1182/blood-2011-01-330738;
     
  7. Girnius S, Dember L, Doros G, Skinner M. The changing face of AA amyloidosis: a single center experience. Amyloid. 2011 Jun; 18 Suppl 1:226-8.View Related Profiles. PMID: 21838497; DOI: 10.3109/13506129.2011.574354085;
     
  8. Seldin DC, Andrea N, Berenbaum I, Berk JL, Connors L, Dember LM, Doros G, Fennessey S, Finn K, Girnius S, Lerner A, Libbey C, Meier-Ewert HK, O'Connell R, O'Hara C, Quillen K, Ruberg FL, Sam F, Segal A, Shelton A, Skinner M, Sloan JM, Wiesman JF, Sanchorawala V. High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution. Amyloid. 2011 Jun; 18 Suppl 1:127-9.View Related Profiles. PMID: 21838459; PMCID: PMC5601311; DOI: 10.3109/13506129.2011.574354047;
     
  9. Dixon BS, Beck GJ, Dember LM, Vazquez MA, Greenberg A, Delmez JA, Allon M, Himmelfarb J, Hu B, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Lawson JH, Cotton JR, Kusek JW, Feldman HI. Use of aspirin associates with longer primary patency of hemodialysis grafts. J Am Soc Nephrol. 2011 Apr; 22(4):773-81. PMID: 21415156; PMCID: PMC3065232; DOI: 10.1681/ASN.2010060582;
     
  10. Dember LM. Fistulas first--but can they last? Clin J Am Soc Nephrol. 2011 Mar; 6(3):463-4. PMID: 21393484; DOI: 10.2215/CJN.00960111;
     
Showing 10 of 51 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.



Contact for Mentoring: